Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03238248
Title Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome


Azacitidine + MLN4924

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.